Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-12 · accession 0001209191-22-029091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | 2022-05-12 | ABCL | Booth Andrew | CFO | P - Purchase | $5.79 | +85.0K | 138.5K | +159% | +$492.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-05-12 | P | A | 85,000 | $5.79 | 138,500 | D | — | — |